Anxiety
VIDEO: Manage sleep care in patients with depression, anxiety
NEW ORLEANS – The American Psychiatric Association added a clinical update track on sleep this year, according to Eric R. Williams, MD, of the University of South Carolina's School of Medicine.
Q&A: Body image concerns in lupus leave patients feeling ‘betrayed,’ ‘out of control’
Although commonly referred to as an “invisible illness,” lupus — and some of its treatments — can manifest in ways that are not only visible, but also heavily impact the daily lives of patients.
Workplaces offering fewer mental health services in 2022, APA poll shows
NEW ORLEANS — Sixty percent of working adults reported knowing how to access mental health services through their employer in 2022, down from 71% in 2021, the 2022 Healthy Minds poll from the APA showed.
Mental health of expatriates negatively affected by incidents occurring in home countries
NEW ORLEANS — Higher levels of depression, anxiety and PTSD were reported by Lebanese expatriates following explosions in Beirut in 2020, according to a speaker at the American Psychiatric Association annual meeting.
Americans more anxious about global events than COVID-19, APA poll shows
NEW ORLEANS – Seventy-three percent of Americans are somewhat or extremely anxious over global events, compared with 50% who reported anxiety over COVID-19, according to survey results shared at the American Psychiatric Association annual meeting.
Anxiety related to COVID-19 associated with uncontrolled asthma in adults
Adults with high levels of anxiety due to COVID-19 during the first few months of the pandemic were more likely to experience uncontrolled asthma, according to a study published in Annals of Allergy, Asthma & Immunology.
Parental anxieties concerning children’s food allergies lessened during COVID-19 shutdown
Most parents saw decreases or no changes in their levels of anxiety related to their children’s food allergies during the COVID-19 lockdown in the spring of 2020, according to a study published in Annals of Allergy, Asthma & Immunology.
FDA designates AI-based therapy for pain, depression, anxiety as breakthrough device
Wysa announced it has received breakthrough device designation from the FDA for its artificial intelligence-based digital mental health conversational agent for adults with chronic musculoskeletal pain, depression and anxiety.
55% of patients have persistent symptoms 2 years after COVID-19 infection
More than half of patients who were hospitalized with COVID-19 reported at least one persistent symptom 2 years post-infection, regardless of initial disease severity, researchers reported.
Postpartum pain associated with anxiety severity
SAN DIEGO — Parturients with more severe postpartum pain experienced more severe anxiety, according to a small study presented here.